Home › Funds › Stonepine Capital Management, LLC › LUNG

Stonepine Capital Management, LLC position in LUNG

PULMONX CORP · Health Care

Stonepine Capital Management, LLC reported holding 815,436 shares of LUNG (PULMONX CORP) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.70% of its reported portfolio and ranking #34 among its reported holdings. Stonepine Capital Management, LLC has disclosed LUNG holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)815.44K sh
Reported value held$1.06M
Portfolio Weight0.70%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's LUNG position evolved

Stonepine Capital Management, LLC first disclosed a stake in LUNG in Q2 2025 at 145,900 shares (US$378K). The position peaked in Q3 2025 at 670,000 shares, worth US$1.1M. Across 5 filings, Stonepine Capital Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 815,436 shares valued at US$1.1M — an increase of 47,148 shares quarter over quarter.. Notable position changes include a 359% increase in Q3 2025 (shares rose 36% over the following quarter), a 27% trim in Q4 2025 (shares fell 42% over the following quarter), a 58% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 145.90K $377.88K New
Q3 2025 670.00K $1.09M Add
Q4 2025 486.40K $1.07M Reduce
Q1 2026 768.29K $991.09K Add
Q2 2026 815.44K $1.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LUNG and 13F data

LUNG (PULMONX CORP) is a Health Care company. 7 other funds we track also report a position in LUNG — the largest reported positions include Almitas Capital LLC (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LUNG

All LUNG fund holders →

FAQ

How long has Stonepine Capital Management, LLC held LUNG?

Stonepine Capital Management, LLC has disclosed LUNG holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Stonepine Capital Management, LLC's current position in LUNG?

As of Q2 2026, Stonepine Capital Management, LLC holds 815.44K shares of LUNG (PULMONX CORP), valued at $1.06M, representing 0.70% of its reported portfolio and ranking #34.

Has Stonepine Capital Management, LLC been buying or selling LUNG?

In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC increased its position in LUNG. The position peaked in Q3 2025 at 670.00K shares.

Which other funds hold LUNG?

Other major institutional holders of LUNG include Almitas Capital LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.